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Summary.-A chromogenic substrate assay for the plasminogen activator (PA)
activity of Lewis lung carcinoma cells has been developed. The cells were incubated
with plasminogen, the activation of which to plasmin was measured by the amido-
lysis of the chromogenic substrate S-2251. This was routinely performed as a 4h
serum-free assay, but a variation lasting 24h, in medium supplemented with
plasminogen-free inhibitor-reduced serum, produced similar results. The assay
also detected PA released into the medium. PA activity was proportional to cell
density, and the assay was non-toxic to the cells.
Assays were performed on cultures derived from primary and metastatic tumours.
Host cells were effectively eliminated from such cultures but, because of an initial
phase of tumour-cell death, PA assays were not carried out until cultures became
established. No consistent difference was detected between PA levels in primary and
metastatic cultures. However, these cultures were shown to be atypical of the parent
tumour; they grew slowly when reinjected at the primary site, and their metastatic
potential was impaired.
SEVERAL CHARACTERISTICS of transfor-
mation or malignancy have been associa-
ted with plasminogen activation. In par-
ticular, there is evidence associating
plasminogen activator (PA) with cellular
migration and invasiveness (Ossowski et
al., 1973; Sherman et al., 1976). Most
tumour cells produce PA, and there is
some evidence that this enzyme may have
a functional role in metastasis. Peterson
(1977) and Kohga (1978) have reported a
correlation between high tumour-cell fib-
rinolysis and the ability to invade and
metastasize, whilst Mohanty et al. (1979)
found significantly higher fibrinolytic acti-
vity in extracts from a metastasizing
tumour than from a non-metastasizing
variant. However, using well character-
ized i.v. injected BI 6 melanoma meta-
static variants, Nicolson et al. (1977)
found no significant differences in PA
levels. In contrast to Nicolson et al. (1977)
we have attempted to investigate PA
levels in cells from primary tumours and
from the spontaneous metastases which
originated from them. On evidence that
selection operates during metastasis (Fid-
ler, 1973) we might expect that if PA had
a role in metastasis the tumour cells of
the metastases would have different levels
of activity from those of the primary
growth.
A variety of assays already exist for
detecting PA (Todd, 1959; Peterson, 1968;
Unkeless et al., 1973; Goldberg, 1974;
Jones et al., 1975; Marsh & Gaffney, 1977).
In many cases it is necessary to prepare
cell sections or lysates, or to collect
serum-free tissue-culture medium over
prolonged periods as sources of PA for
assay. The activity in such samples is
unlikely to reflect the PA activity of the
cell. We have therefore investigated the
possibility of assaying PA in intact, live
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cells under conditions which are, as
nearly as possible, physiological. This
would provide a useful alternative to the
above assays, and a simpler and more
readily quantifiable addition tothe method
for measuring PA on live cells by monitor-
ing the lysis of radiolabelled fibrin (Unke-
less etal., 1973).
Recently, a number of chromogenic
peptide substrates have been synthesized,
the specificity of which is obtained either
by imitation of the natural substrate, in
particular the amino acid sequence pre-
ceding the scissile bond, or by trial-and-
error substrate structure and enzymic
activity correlations (Claeson et al., 1978).
Those produced by the latter technique
include H -D-valyl -L -leucyl -L -lysine -p -
nitroanilide dihydrochloride (S-2251, Kabi-
Vitrum Ltd, London) which releases a
prominent yellow dye, p-nitroaniline,
when degraded, and has a degree of speci-
ficity for plasminogen-streptokinase com-
plex and plasmin (Claeson et al., 1979). We
have used this substrate to detect PA
activity in live cells incubated in the
presence ofplasminogen and the substrate.
Reliable measurements of tumour-cell
PA levels can only be obtained after re-
moval of contaminating host cells, since
these may be sources ofPA (Unkeless et al.,
1974). We have therefore undertaken the
removal of these cells. Furthermore, the
cells under test shouldbeintact, viable, and
have recovered from the proteolytic treat-
ments applied during harvesting. Since it
became clearthat only established cultures
were satisfactory in this respect, assays
were limited to this type of material. The
in vivo characteristics ofsuch cultures were
compared to those of the parent tumours
by reinjecting them into mice.
MATERIALS AND METHODS
The Lewis lung carcinoma usedin this study
is described elsewhere (Magudia et al., 1980).
Briefly, a stable line was maintained by
reinjecting 20,000 primary tumour cells into
the hind legs of C57BL/10 ScSn mice, which
were killed when the primary tumour had
reached a diameter of 10 mm.
Cells with >95% viability were suspended
from pooled tumours, using the techniques
of Stephens et al. (1977). They were plated
into tissue-culture dishes and incubated in an
enriched Dulbecco's medium with 20% foetal
bovine serum. Most cells attached, but some
tumour cells and all the lymphocytes and
polymorphonuclear leucocytes failed to do so.
These cells were lost during subsequent
washing. Macrophages adhered well and were
identified as Fc-receptor-positive cells by
incubating the washed cultures with opson-
izedsheepredblood cells for30min.Theywere
eliminated by resuspending the cultures with
trypsin-EDTA and transferring them to a
new dish. One to three such passages freed the
cultures of macrophages.
Cell size was determined on a cell counter
fitted with a P64 channel analyser (Coulter
Electronics, Harpenden, Herts.) and viability
was determined bytrypan-blue dye exclusion.
For the assay of PA, phenol-red-free Dul-
becco's medium (DMEM, Flow, Irvine, Scot-
land) was used as a solvent for all reactants.
Lyophilized human plasminogen and plasmin
(KabiVitrum) were used freshly made up.
S-2251 (KabiVitrum) was stored at 4°C as a
5mM stock solution. It could not be sterilized
by filtration without loss of substrate.
Human urokinase (Leo, Hayes, Middx) and
epsilon-aminocaproic acid (EACA, Sigma,
Poole, Dorset) were used freshly made up.
Carbowax 6000 (Union Carbide) was used
at 5 g/l. The acid- or heat-treated foetal calf
serum was freed of plasminogen by affinity
chromatography on lysine-sepharose and had
reduced levels of inhibitors of plasmin
(Northumbria Biologicals, Cramlington,
Northumberland). This serum is known to
support cell growth (Whur et al., 1979).
The assay was performed on cells growing in
96-well trays (Falcon, Oxnard, Calif., U.S.A.)
incubated for 4 h in the presence ofplasmino-
gen and S-2251. 01 ml of serially diluted
cells, ranging from 2-5 x 105 to 3-1 x 104
cells/ml, were seeded into the trays with 6
replicates at each cell concentration. These
were incubated overnight in nornmal growth
medium and then washed in 3 changes of
unsupplemented DMEM. A duplicate set of
rows was used for detection of plasminogen-
independent amidolysis. As an alternative
procedure, cells freshly suspended from cul-
tures using a rubber policeman, and not
treated with proteases, were used at the same
concentrations. Plasminogen was added atLEWIS LUNG PLASMINOGEN ACTIVATOR
1 casein unit (cu)/ml and S-2251 at 1mM final
concentration. The total volume was 0-2 ml
per well. Incubation was carried out at 37°C
in a CO2 incubator, and the amidolytic reac-
tion was read at 405 nm on an automated
spectrophotometer specifically designed for
96-well trays (Multiskan, Flow). Each set of
readings was blanked against the correspond-
ing plasminogen-free controls, and the net
change in absorbance (OD) attributable to the
activation of plasminogen was calibrated
against serial dilutions of urokinase, assayed
under identical conditions in the same trays.
Cells were recovered from the monolayers
with trypsin/EDTA and counted, and a best-
fit curve of PA against cell density was com-
puted. From this the OD attributable to the
spontanleous, PA-independent, activation of
plasminogen was detected, as residual amido-
lytic activity at zero cell density, and
eliminated.
The fibrin-agarose overlay assay was per-
formed as described by Jones et at. (1975).
Allgraphs were computer-generated best-fit
curves. Channel analyser results were redrawn
from actual single plots, and pooled data are
expressed as means and standard errors.
RESULTS
Design ofchromogenic substrate assay
A number of experiments were under-
taken to optimize the assay conditions.
The sensitivity did not increase linearly
with time; over a 4h period OD increased
relatively faster than incubation time
(Fig. 1); 4 h was chosen arbitrarily as a
period over which cells could be incubated
safely in the absence ofserum. 1mM S-2251
produced an OD response linear with
plasmin concentration up to a maximum
OD of 7 (Fig. 2), indicating that the
S-2251 was present in sufficient excess to
be non-limiting. It was not possible to
establish a non-rate-limiting concentration
of plasminogen; we found that doubling
plasminogen concentrations up to a maxi-
mum of 10 cu/ml (the practical limit)
always doubled the amidolytic activity.
The routine concentration of 1 cu/ml was
arbitrarily adopted because it generated
suitable OD levels in our system. EACA





O |1 2 3 4
Time th)
FiG. 1.-Effect of increasing the incubation
period on the OD generated by different
densities ofcells in the presence ofplasmin-
ogen and S-2251. Readings have been cor-
rected against duplicate plasminogen-free
controls. All 4 curves are similar; the in-
crements in OD increase with each incu-
bation period. Cell densities (per cm2):
* 1-8 x 104, * 1-2x 104, A 1 X 104,
C] 8-9 x 103.
activation when added at up to 14mM
final concentration, but addition of even
minute amounts of EACA produced
marked inhibition of tumour-cell PA-
mediated activation. EACA was not,
therefore, used in this assay.
Plasmin concentrations > 0-002 cu/ml
were proportional to OD (Fig. 3). Smaller
quantities of plasmin were partially lost,
possibly by adhesiontothevessel walls, al-
though this phenomenon was not affected
by the addition of carbowax. When uro-
kinase was used to activate plasminogen,
OD was linear across the whole OD range.
No totally satisfactory standardization
method for this assay currently exists.
The particular PA under investigation
has not yet been isolated, and plasmin is
theoretically unacceptable as an alterna-
tive to the multi-stage chromogenetic
pathway ofthe assay. Urokinase, although
it clearly activates plasminogen by a
process distinct from that ofthe PA under
investigation, is the most satisfactory
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Performance of chromogenic substrate assay
8 - Increases in OD were attributable to a
variety offactors apart from PA-mediated
activation of plasminogen. Evaporation
6
- caused small increases (up to 0.03) but no change in OD was associated with the
spontaneous breakdown of S-2251. Plas-
4
- minogen invariably produced increases in
OD which were linearly related to its
concentration, but the activity varied
2 slightly between batches. Another source
of OD increase was the cells themselves;
this direct amidolysis of S-2251 by cells
was linearly related to cell density (Fig. 4).
0 0-05 0-1 0-15 0-2 0 25 The major change in OD was due to the activation ofplasminogen by the cells, and
Plasmin (CUml) this was also linearly related to cell density
-G. 2. OD generated by maximum degra- (Fig. 4). This reaction was inhibited (95%)
dation of 8-2251. ImAi S-2251 was incu- by EACA at 2mM. Cells in suispension gave bated witbl a range of plasmin concen- qualitatively similar results to cells in
trations. Up to OD 7 thtere was a linear
relationsbip with plasma in concentration, monolayer, but PA levels were reduced by
indicating that the substrate was in 30-4000. The cells and medium also con-
allA;a+.an -r-, -A--;nf flThn n sumcient excess ior experiments 1wnose utJs
were within this range. Above this level
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FIG. 3. Plasmin stan(dard curve against
S-2251. Plasmin was incubated for 4 b1 witb
1mM S-2251 at 37°C. Plasmin concentration
was proportional to OD except at concen-
trations below 2 x 10-3 cu/ml.
alternative and can be adopted provided
lysine, or lysine analogues like EACA,
have been excluded from the assay system.
-04
0.D.
Uo 05 1 1-5 2
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FIG. 4. Plasminogen activation by Lewis
lung carcinoma cells. The cells were grown
in 96-well trays an(d the assay was read
witb cells andl incubation medium in situ,
using an automated spectrophotometer.
Both curves are linear. Incubation was with
(U) or without (O) plasminogen, an(d the
(lifference between the curxves is the OD
attributable to the (direct effect of PA on
plasminogen. In this particular instance
no plasmin is detectable as a contaminant
of the added plasminogen, since zero cells
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tributed to the background; when using
the empty tray as a blank, the highest
density of cells produced an OD of 0 03,
and an OD of 0 09 was produced by
DMEM alone.
A variation of the routine assay was
used to detect PA released into the
medium. After 4h incubation with washed
cells, harvested medium contained in-
sufficient PA to be detected. The presence
of small amounts of PA was subsequently
confirmed in such samples by doubling the
plasminogen concentration and by reading
the OD in a spectrophotometer with a
1Omm path length. Mediumharvestedafter
18 h, however, contained sufficient PA
to be detected by the routine 96-well
procedure. In another variation of the
assaywe addedplasminogen-free inhibitor-
reduced serum to the medium, to enable
the incubation period to be prolonged,
since this seemed a useful modification for
some tissue culture studies. In 24h incuba-
tions with supplemented medium the
results resembled those obtained with the
routine assay. However, the serum itself
hadsubstantial amidolytic activity against
S-2251, and the PA-dependent OD's
generated were slightly lower than in the
routine version of the assay, presumably
because of residual inhibitory activity in
the serum.
Initial viability was always 100% in
monolayers and varied between 70 and
95% for cells harvested mechanically for
subsequent assay in suspension. The
viability of cells did not alter after either
the 4h or 24h incubation procedures. The
cells in monolayer tended to round up in
serum-free medium, and detached in large
numbers into 18h serum-free harvested
medium. However, their appearance was
unaffected by the 24h assay procedure,
which included serum in the incubation
mixture.
Establishment ofcell cultures
In freshly harvested tumour material,
lymphocytes and polymorphonuclear leu-
cocytes failed to attach to tissue culture
vessels, and disappeared from washed
. - , ~~~177|1 I -
.0 2 40
No. -of -days in cultureI
FIG. 5.-Growth ofLewislungcarcinoma cells
in monolayer culture. Freshly harvested
cells from aprimary leg tumour were seeded
on Day O and cell density was monitored
for 5 weeks. For the first few days there
was massive death and shedding of cells,
resulting in a 95% decline in cell density.
This was followed by a period of rapid
growth of a few clones of cells within the
culture, accounting for the large standard
errors when counts from different dishes
were pooled. Such Nultureshave now been
maintained without alterations in their
growth pattern for more than a year
and may be considered to be permanently
established.
monolayers. Macrophages persisted until
removed by the technique described.
Within 2-3 days pure tumour-cell cultures
were obtained, only rarely contaminated
by host fibroblast-like cells; in which case
the tumour cultures were displaced by
these cells within 1-4 weeks. Newly
established cultures were examined for
their suitability for enzyme assay. It
became apparent that such cultures were
dying back rapidly, as evidenced by the
decreasing cell density during the first 2
weeks in culture (Fig. 5) coupled with the
recognition of cells, which looked intact
under the microscope, as electrolyte-
permeable when examined on the Coulter
channel analyser (Fig. 6). After 2-3 weeks
a small number of clones emerged from
the low-density cultures and these re-
populated the dishes (Fig. 5) with viable
cells (Fig. 6). Such cultures were desig-
nated as established because they con-
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tinued to grow rapidly for an indefinite
period.
PA levels in cell cultures
Attempts to assay PA in cultures imme-
diately after the removal ofhost cells were
unsuccessfulbecauseoftherapidrateofcell
death during the first few days in culture
(Figs 5 and 6). The assays were therefore
performed on cultures which hadstarted to
increase in density. When cultures of
primary and metastatic origin were com-
pared, there was no consistent difference
in the levels of PA. In 22 separate assays
the mean levels ofPA per cell were 1 05 +
0 37 and 0 95+ 0-24 i.u. of urokinase
x 10-6 for cells of primary and metastatic
origin respectively. This combined data,
however, masks the considerable variation
100
Frequency
0 1 2 3 4
Cell volume (pm3 x 1O3
FiG. 6. Size distribution of cultured Lewis
lung carcinoma cells, derived from one
generation ofprimary and metastatic estab-
lished cultures. In these notional single-cell
suspensions a proportion of cells form
aggregates of 2 or more cells, producing
a skew to the right. We have assumed
that the most frequent species (the mode)
represents the mean size of the single-cell
population. On this basis, these particular
leg and lung cells had diameters of 13-5
,um and 14-6 ,um respectively. The dotted
line shows the plot from an unestablished
monolayer culture. The modal diameter
is 6-5 ,am, and expresses the substantial
degree ofcell disintegration in such cultures,
which rendered meaningful PA assays
impossible.
observed when different generations ofthe
tumour were compared. For example, in
the 6th generation, metastatic cultures
consistently produced significantly higher
levels of PA than primary cultures, while
the reverse was true in the case ofthe 11th
generation. Similar heterogeneity was ap-
parent in respect of cell size (Fig. 6) when
the same generations ofprimary and meta-
static tumour were compared, but, again,
there was no overall difference when data
were pooled.
In order to determine the source of PA
heterogeneity, clones wereestablishedfrom
a primary tumour and examined for PA
activity against fibrin-agarose overlays
(Fig. 7). Individual clones clearly had
different fibrinolytic activities.
Reinjection ofcell cultures
In order to detect any changes which
may have occurred during adaptation to
monolayer culture, cells from established
ia. 7. PA activity in clones of a primary
Lewis lung carcinoma. The clones have been
overlayed with plasminogen-containing
fibrin agarose, and plasminogen-free dishes
(lid not exhibit non-specific fibrinolysis.
Although not a quantitative technique, it
is obvious that the clones are heterogeneous
with respect to PA production. Similarities
between adjacent clones are probably
indicative of a common origin, since these
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or metastatic origin (Fig. 4). Cells in suspension may be sub-
mice under conditions stituted for monolayers, but they give
of the parent tumour. lower OD readings, so the 2 methods
rate of the primary are not interchangeable. Since the OD
metastatic potential, generated is not proportional to time
7 impaired by their (Fig. 1) a standard incubation period is
layer culture (Table). recommended. Prolonged incubation can
be achieved by the addition of inhibitor-
haracteristics of Lewis reduced, plasminogen-free serum, but sen-
established in tissue sitivity is not increased. The addition of
to parent line. In both serum may, however, be useful for some
)m established cultures PA studies with established cell lines.
duce palpable primary Assay of harvested medium by the same
en took longer to grow. technique permits the detection of PA
nged period for which released into the medium. In the case of
were present, the meta- Lewis lung carcinoma cells, only a small pas significantly (P < fraction ofthe activity ofthe live cells was
present in the medium, even after 18 h.
No ideal standardization method currently Cultured exists for the assay, but provided lysine 'arent Cultured meta-
line primary stasis or its analogues are absent, the calibration
6+0.5 14-2+0-6 28-9+2-2 ofODs against asimultaneouslyperformed
2+ 0-2 11-0+0-6 27-1+2-0 urokinase standard curve provides a con-
venient and reproducible reference. EACA
25 33 66 should not in any case be used, since it
reduces assay sensitivity. The assay is
5+1 9+4 22±+5 non-toxictothe cells, andthe onlymorpho-
logical effects noted were attributable to
USSION serum deprivation.
Chromogenic substrate assayforPA
A chromogenic substrate assay has been
developed which detects the PA activity
of live cells under nearly physiological
conditions. Essentially, the PA of intact
cells activates added plasminogen to
plasmin, the presence of which is simul-
taneously detected by the chromogenic
substrate S-2251, incorporated into the
incubation medium. Under defined condi-
tions, the change in OD is proportional to
PA activity. The method describedisbased
on the use of 96-well trays and the reading
of OD in situ on an automated spectro-
photometer. However, the assay can also
be performed in other culture dishes, the
OD being read after transferring the
incubation medium to a standard cuvette.
The sensitivity of the assay can be in-
creased by increasing the concentration
of plasminogen, or by using more cells
Establishment ofcellcultures
The primary aims ofthis procedure were
to eliminate host cells and to allow the
tumour cells to recover from the trauma
and enzyme-induced damage occurring
during tumour harvesting. With the
exception of a few cultures contaminated
by host fibroblast-like cells, which were
readily detected and discarded, these aims
were achieved. Unfortunately, however, it
became apparent that such newly seeded
cultures contained a very high proportion
of dying tumour cells (Figs. 5 and 6), and
only a minute fraction of the original cells
survived to form the established culture
(Fig. 5).
PA levels in primary and metastatic
cultures
In the pooled data from 22 separate
experiments carried out onseveraldifferent
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generations of the tumour, no overall
difference was seen between the PA levels
of cells from primary and metastatic
cultures. However, within any single
generation, reproducible differences in PA
levels and cell size (Fig. 6) were apparent
when primary and metastatic cultures
were compared. This was probably due to
the partial cloning of cultures which oc-
curred duringtheir establishment in mono-
layer (Fig. 5), giving rise to cultures with
individual PA characteristics. This view is
supported by the facts that established
clones from primary tumours were clearly
very heterogeneousforPA activity (Fig. 7)
and that when such cultures have been
reinjected their growth rates and meta-
static potentials have varied considerably.
Reinjection of established cultures
When established cultures were re-
injected into mice it was apparent that
their characteristics were substantially
different from those of the parent line,
and that both the growth rate of the
primary tumours and their metastatic
potential were greatly reduced (Table).
Since these lines were so untypical oftheir
originating tumour, the levels of PA
detected in such material must be con-
sidered to be characteristic ofthe partially
cloned established monolayer cultures
and not of the tumours themselves.
General conclusions
The original purpose ofthis work was to
determine whether PA levels were different
in primary and metastatic Lewis lung
carcinomas. For this purpose a chromo-
genic substrate assay was developed
which measures PA activity in live cells,
and which we consider offers considerable
theoretical and practical advantages over
any other published assay technique. We
resorted to the use of established cultures
because we do not yet possess the technical
capacity to examine undamaged, purified
tumour cells directly after harvesting.
Many of the problems involved in this
field have been discussed by Fidler et al.
(1979) who also resorted to the use of
cultures, and by Guy et al. (1979) who have
made some progress towards the use of
freshly harvested cells. The work reported
here suggests that, at least in respect of
PA, levels in cultured cells indicate the
selection forgrowth in monolayer, andmay
not reflect the levels in the original tumour
cells. Since our cultured cells had lowered
tumorigenicity and metastatic potential,
PA levels in these cultures might be lower
than in the native tumour. Work in pro-
gress, indicating that Lewis lung car-
cinomas contain some very high-PA clones
which can be selected under conditions of
non-anchorage dependence, tends to con-
firm this view.
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